FLGT financials
Fulgent Genetics (FLGT) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
FLGT income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $322.67M | $130.88M | -$91.10M | -$60.51M | -1.97 |
| 2024 | $283.47M | $107.22M | -$73.92M | -$42.71M | -1.41 |
| 2023 | $289.21M | $104.46M | -$195.53M | -$167.82M | -5.63 |
| 2022 | $618.97M | $366.90M | $178.53M | $143.40M | 4.63 |
| 2021 | $992.58M | $777.05M | $675.95M | $507.36M | 16.26 |
| 2020 | $421.71M | $331.90M | $290.16M | $214.31M | 8.91 |
- FLGT revenue was $322.67M in fiscal 2025, net income -$60.51M.
Updated 2026-11-07 11:56 UTC